Cargando…

Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor

p53 is a key protein that participates in cell-cycle control, and its malfunction can lead to cancer. This tumour suppressor protein has three main domains; the N-terminal transactivation domain, the CTD (C-terminal domain) and the core domain (p53C) that constitutes the sequence-specific DBD (DNA-b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Jerson L., Rangel, Luciana P., Costa, Danielly C. F., Cordeiro, Yraima, De Moura Gallo, Claudia V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728989/ https://www.ncbi.nlm.nih.gov/pubmed/24003888 http://dx.doi.org/10.1042/BSR20130065

Ejemplares similares

The aggregation of mutant p53 produces prion-like properties in cancer
por: Rangel, Luciana P, et al.
Publicado: (2014)

Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils: IMPLICATIONS FOR CANCER
por: Ano Bom, Ana P. D., et al.
Publicado: (2012)

RNA modulates aggregation of the recombinant mammalian prion protein by direct interaction
por: Kovachev, Petar Stefanov, et al.
Publicado: (2019)

Ligand Binding and Hydration in Protein Misfolding: Insights from Studies of Prion and p53 Tumor Suppressor Proteins
por: Silva, Jerson L., et al.
Publicado: (2009)

Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer
por: de Oliveira, Guilherme A. P., et al.
Publicado: (2015)

PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma
por: Paz, Mariana M., et al.
Publicado: (2023)

Virtual drug screening for prion diseases: A valuable step?
por: Cordeiro, Yraima
Publicado: (2016)

Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria
por: Macedo, Bruno, et al.
Publicado: (2015)

Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target
por: Ferraz da Costa, Danielly C., et al.
Publicado: (2017)

Anticancer Therapeutic Strategies Targeting p53 Aggregation
por: Ferretti, Giulia D. S., et al.
Publicado: (2022)

Prion Protein Complexed to N2a Cellular RNAs through Its N-terminal Domain Forms Aggregates and Is Toxic to Murine Neuroblastoma Cells
por: Gomes, Mariana P. B., et al.
Publicado: (2008)

Resveratrol prevents p53 aggregation in vitro and in breast cancer cells
por: Ferraz da Costa, Danielly C., et al.
Publicado: (2018)

Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids
por: Macedo, Bruno, et al.
Publicado: (2017)

Copper drives prion protein phase separation and modulates aggregation
por: do Amaral, Mariana Juliani, et al.
Publicado: (2023)

The p53 Core Domain Is a Molten Globule at Low pH: FUNCTIONAL IMPLICATIONS OF A PARTIALLY UNFOLDED STRUCTURE
por: Ano Bom, Ana Paula D., et al.
Publicado: (2010)

Rabbit PrP Is Partially Resistant to in vitro Aggregation Induced by Different Biological Cofactors
por: Angelli, Juliana N., et al.
Publicado: (2021)

Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands
por: Petronilho, Elaine C., et al.
Publicado: (2021)

Dominant Prion Mutants Induce Curing Through Pathways That Promote Chaperone-Mediated Disaggregation
por: DiSalvo, Susanne, et al.
Publicado: (2011)

p53 tetramerization: at the center of the dominant-negative effect of mutant p53
por: Gencel-Augusto, Jovanka, et al.
Publicado: (2020)

Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function
por: Palanikumar, L., et al.
Publicado: (2021)

Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cells
por: Melo dos Santos, Nataly, et al.
Publicado: (2019)

Treating p53 Mutant Aggregation-Associated Cancer
por: Kanapathipillai, Mathumai
Publicado: (2018)

Profilin 1 mutants form aggregates that induce accumulation of prion-like TDP-43
por: Tanaka, Yoshinori, et al.
Publicado: (2016)

Epigenetic Dominance of Prion Conformers
por: Saijo, Eri, et al.
Publicado: (2013)

A dominant-negative mutant inhibits multiple prion variants through a common mechanism
por: Pei, Fen, et al.
Publicado: (2017)

The Expanding Universe of Prion Diseases
por: Watts, Joel C, et al.
Publicado: (2006)

The Status of p53 Oligomeric and Aggregation States in Cancer
por: de Oliveira, Guilherme A. P., et al.
Publicado: (2020)

Aggregation tendencies in the p53 family are modulated by backbone hydrogen bonds
por: Cino, Elio A., et al.
Publicado: (2016)

The Role of Crowded Physiological Environments in Prion and Prion-like Protein Aggregation
por: Ma, Qian, et al.
Publicado: (2013)

Bifunctional ligand design for modulating mutant p53 aggregation in cancer
por: Miller, Jessica J., et al.
Publicado: (2019)

Reduced Levels of Misfolded and Aggregated Mutant p53 by Proteostatic Activation
por: Naus, Evelyne, et al.
Publicado: (2023)

Yeast Prions: Protein Aggregation Is Not Enough
por: Sherman, Michael Y
Publicado: (2004)

Immunopurification of Pathological Prion Protein Aggregates
por: Biasini, Emiliano, et al.
Publicado: (2009)

Role of Prion Protein Aggregation in Neurotoxicity
por: Corsaro, Alessandro, et al.
Publicado: (2012)

Quaternary structure of the specific p53–DNA complex reveals the mechanism of p53 mutant dominance
por: Aramayo, Ricardo, et al.
Publicado: (2011)

PRION 2019 emerging concepts
Publicado: (2019)

Bioactive Compounds and Metabolites from Grapes and Red Wine in Breast Cancer Chemoprevention and Therapy
por: Ferraz da Costa, Danielly C., et al.
Publicado: (2020)

Aminoquinolones and Their Benzoquinone Dimer Hybrids as Modulators of Prion Protein Conversion
por: Costa, Amanda Rodrigues Pinto, et al.
Publicado: (2022)

Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation
por: Kaypee, Stephanie, et al.
Publicado: (2018)

Understanding p53 tumour suppressor network
por: Panatta, Emanuele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lbg2fhm5segegltlodd49kp3bi